Westwicke Hires New Senior-Level Director to Specialize in Pharmaceuticals and Biotechnology
Baltimore, Md., March 11, 2015 — Westwicke, the largest healthcare-focused investor relations (IR) firm in the country, announced today the addition of Patti Bank as a new Managing Director to lead the fast-growing Life Sciences division of its San Francisco office. Ms. Bank will provide strategic investor relations and capital markets advisory services to public and private healthcare companies, with a focus on pharmaceutical/specialty pharmaceutical and biotechnology.
“Patti brings to Westwicke substantial success on Wall Street, on top of a remarkable background in the healthcare sector,” said Bob East, a Managing Partner at the firm. “This unique combination will make her invaluable to companies preparing to go public and existing public companies that need a more strategic investor relations plan. The life sciences sector in the Bay area is growing very quickly, and Patti is the perfect person to help guide companies’ through the public offering process and beyond.”
Ms. Bank’s Wall Street experience includes more than 20 years as a sell-side equity analyst covering the pharmaceutical and specialty pharmaceutical sectors, along with five years as a senior pharmaceutical medical representative. Most recently, she served as a Managing Director at Discern Analytics, where she founded the company’s healthcare vertical and developed a large-scale data analytics platform to track early investment trends affecting specialty pharmaceutical stocks.
Previously, Ms. Bank was a Senior Vice President at Pacific Growth Equities (acquired by Wedbush) and at Vector Securities (acquired by Prudential), two research and strategic advisory firms focused on small-to-mid capitalization healthcare companies. In these roles, she participated in several initial public offerings, capital raises, and mergers and acquisitions. She also covered companies across a broad range of therapeutic areas, from gastrointestinal and respiratory to pain management, diabetes, dermatology, and the central nervous system.
“Westwicke’s unique focus on healthcare and strategic approach to investor relations makes it an excellent career move for me,” said Ms. Bank. “I’m thrilled to join a team of professionals who are at the cutting-edge of healthcare IR, and I’m ready to help companies reach their full potential.”
“Patti’s track record on Wall Street and in the pharmaceutical and biotech industries are incredibly impressive,” said Mark Klausner, a Managing Partner at Westwicke. “We’re looking forward to working with her and so glad to make her a core part of our team.”
Westwicke provides customized strategic investor relations programs and independent capital markets advice to public and private healthcare companies. For more information, please contact Tom McDonald at 443-213-0508 or email@example.com, or visit www.westwickepartners.com.